Topical and Transdermal Focus MedPharm-US specializes in topical and transdermal drug delivery systems and owns a growing patent portfolio around MedSpray, MedRo, MedTherm, and AquaRMed. Sales opportunities exist in licensing these technologies to pharmaceutical and biotech companies seeking novel delivery platforms for skin, nail, mucous membrane, eye, nose, and lung applications.

In-house Development Pipeline The company has built an internal development pipeline, indicating readiness for collaboration on joint development agreements or licensing deals to commercialize its delivery technologies with partners who need advanced topical formulations.

Healthcare and Disease Models MedPharm-US offers expertise in performance testing of topical formulations and development of biological disease models, presenting an opportunity to contract R&D services for external clients pursuing preclinical or formulation validation work.

Strategic Partnership Potential With a focus on licensing its proprietary delivery systems to third parties, there are clear sales avenues for partnerships or co-development arrangements with midsize to large pharma players seeking differentiated topical delivery platforms.

Financial and Market Readiness Revenue is in the modest multi-million range, suggesting a scalable model with room for larger collaborations. Potential customers may include competitors and peers in the pharmaceutical and biotech space looking to augment their product portfolios with validated transdermal and topical technologies.